Pharvaris NV

As of April 24, 2025, Pharvaris NV's trend is mildly bearish, driven by daily moving averages, while mixed signals from MACD, Bollinger Bands, and KST indicate a lack of strong bullish momentum.

Pharvaris NV is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $49 million and a market cap of $902.41 million. Key metrics include a negative P/E ratio, no dividend yield, and a return on equity of -67.24%.

As of Jun 18, Pharvaris NV has a market capitalization of 902.41 million, with net sales of 0.00 million and a net profit of -163.68 million over the latest four quarters. Shareholder's funds are 277.27 million, and total assets amount to 301.72 million.